CYTOVANT
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment.
CYTOVANT
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2019-04-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.cytovant.com
Total Employee:
1+
Status:
Active
Contact:
+86 21 5090 0866
Email Addresses:
[email protected]
Total Funding:
23.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Euro ASP.NET Pound Sterling Japanese Yen Alibaba HiChina DNS China Ministry Of Public Security
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Current Employees Featured
Founder
Investors List
BNH
BNH investment in Venture Round - Cytovant
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Venture Round - Cytovant
Smilegate Investment
Smilegate Investment investment in Venture Round - Cytovant
POSCO Venture Capital
POSCO Venture Capital investment in Venture Round - Cytovant
More informations about "Cytovant"
Cytovant 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Cytovant. Use the PitchBook Platform to explore the full profile.See details»
Cytovant Sciences Co., Ltd. - LinkedIn
Cytovant Sciences Co., Ltd. | 46 followers on LinkedIn. Cytovant is a biopharmaceutical company dedicated to developing novel and innovative cellular therapeutics in Asia. | Cytovant Sciences is a ...See details»
Cytovant Sciences Company Profile - Office Locations ... - Craft
Cytovant Sciences has 1 employees across 2 locations. See insights on Cytovant Sciences including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Cytovant - Overview, News & Similar companies | ZoomInfo.com
Cytovant is a clinical-stage biopharmaceutical company focused on developing innovative cellular therapeutics in Asia. Cytovant's mission is to become Asia's premier cell therapy company by …See details»
Cytovant Sciences HK Ltd. - life-sciences-asia.com
Oct 19, 2020 Advertisement Cytovant Sciences HK Ltd. Cytovant Sciences HK Limited, owner of Cytovant Sciences Co., Ltd and affiliate of Roivant Asia Cell therapy Holdings Ltd, is a clinical …See details»
Roivant and Sinovant Launch Cytovant Sciences in Partnership …
The launch of Cytovant represents an important milestone in Sinovant’s evolution as a platform for entrepreneurs like John and we look forward to building Cytovant with him.” About Cytovant …See details»
Cytovant Sciences - VentureRadar
Imvax USA Privately Held Imvax™ is a clinical-stage biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies for the …See details»
Cytovant - Crunchbase Company Profile & Funding
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.See details»
Cytovant - Products, Competitors, Financials, Employees, …
About Cytovant Cytovant, established by Roivant Sciences and Sinovant Sciences, is a clinical-stage biopharmaceutical company focused on developing cellular therapeutics in Asia. …See details»
Roivant and Sinovant launch biopharma firm Cytovant …
Roivant Sciences and Sinovant Sciences have launched a new biopharmaceutical firm Cytovant Sciences to cater to patients across Asia.See details»
Roivant and Sinovant Launch Cytovant in $1 Billion-Plus Deal With ...
Apr 4, 2019 Partnering with Hong Kong-based Sinovant Sciences, which is one of Ramaswamy’s “vant” companies, Roivant and Sinovant are launching a company called …See details»
ROIVANT AND SINOVANT LAUNCH CYTOVANT SCIENCES IN …
About Cytovant Cytovant is a clinical-stage biopharmaceutical company focused on developing innovative cellular therapeutics in Asia. Cytovant's mission is to become Asia's premier cell …See details»
Cytovant - Funding, Financials, Valuation & Investors
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.See details»
Cytovant Sciences Launched by Sinovant and Roivant in …
Apr 9, 2019 Sinovant Sciences and Roivant Sciences announced the launch of Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing …See details»
Cytovant Sciences - VentureRadar
Global healthcare company Roivant Sciences and Chinese drugmaker Sinovant Sciences launched biopharmaceutical firm Cytovant Sciences to cater to patients across Asia.See details»
Medigene AG: Roivant and Sinovant Launch Cytovant Sciences in ...
Roivant Sciences and Sinovant Sciences announced the launch of Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing innovative cellular …See details»
Medigene AG: Roivant and Sinovant Launch Cytovant Sciences in ...
Apr 5, 2019 The launch of Cytovant represents an important milestone in Sinovant’s evolution as a platform for entrepreneurs like John and we look forward to building Cytovant with him.” …See details»
Cytovant - Contacts, Employees, Board Members, Advisors & Alumni
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.See details»
Sinovant and Roivant Sciences Launch Cytovant Sciences
Apr 4, 2019 Sinovant Sciences and Roivant Sciences have launched Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing innovative cellular …See details»
Cytovant - Crunchbase
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.See details»